Carta al EditorRéplica. Lopinavir/ritonavir en monoterapia: ¿para quién y cuándo?Author's response. Lopinavir/ritonavir monotherapy: For whom and when?
Bibliografía (10)
- et al.
De la investigación a la práctica clínica: uso de lopinavir/ritonavir en monoterapia
Enferm Infecc Mioclobiol Clin
(2008) - Tratamiento de simplificación: lopinavir/ritonavir con o sin efavirenz. Enferm Infecc Microbiol Clin;...
- et al.
Lopinavir/ritonavir as a single-drug Therapy for manteinance of HIV-1 viral suppression: 48-weeks results of a randomized, controlled, open-label, proof-of-concept pilot clinical trial (OK Study)
J Aquir Immune Defic Syndr
(2005) - Arribas JR, Pulido F, Delgado R, Cabrero E, Cepeda C, González-García J, et al. Lopinavir/ritonavir as single-drug...
- Riddler SA, Haubrich R, DiRienzo G, Peeples L, Powderly WG, Klingman KL. AIDS Clinical Trials Group 5142 Study Team. A...
There are more references available in the full text version of this article.
Cited by (0)
Copyright © 2009 Elsevier España, S.L. All rights reserved.